STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2014

The Company records stock-based compensation in accordance with the provisions of ASC 718, “Compensation-Stock Compensation.” The Company’s results for the three months ended March 31, 2014 and 2013 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

	Increase/(Decrease) for the Three Months Ended March 31,
	2014			2013
Cost of sales	$	148		$	152
Operating expenses		840			924
Net earnings		(653	)		(670	)

Summary of stock option activity

Option activity for the three months ended March 31, 2014 and 2013 is summarized below:

For the three months ended March 31, 2014	Shares (000s)			Weighted Average Exercise Price		Aggregate Intrinsic Value ($000s)		Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2013		1,893		$	20.94	$	71,465
Granted		158			50.57
Exercised		(125	)		10.60
Forfeited		(13	)		43.10
Outstanding as of March 31, 2014		1,913		$	23.92	$	53,946		5.6
Exercisable as of March 31, 2014		1,504		$	19.28	$	49,392		4.7

For the three months ended March 31, 2013	Shares (000s)			Weighted Average Exercise Price		Aggregate Intrinsic Value ($000s)		Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2012		2,543		$	16.87	$	49,845
Granted		166			38.10
Exercised		(183	)		11.42
Outstanding as of March 31, 2013		2,526		$	18.67	$	63,825		5.4
Exercisable as of March 31, 2013		2,015		$	14.89	$	58,552		4.4

Other information pertaining to stock option activity

Other information pertaining to option activity during the three months ended March 31, 2014 and 2013 was as follows:

	Three Months Ended March 31,
	2014			2013
Weighted-average fair value of options granted		$	15.98		$	12.85
Total intrinsic value of stock options exercised ($000s)		$	5,418		$	5,097

Non-vested restricted stock activity

Non-vested restricted stock activity for the three months ended March 31, 2014 and 2013 is summarized below:

Three months ended March 31, 2014	Shares (000s)			Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2013		172		$	33.69
Granted		20			50.49
Vested		(2	)		35.79
Forfeited		(2	)		32.70
Non-vested balance as of March 31, 2014		188		$	35.42

Three months ended March 31, 2013	Shares (000s)			Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2012		258		$	26.88
Granted		21			38.10
Vested		(2	)		35.79
Non-vested balance as of March 31, 2013		277		$	27.66

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References+ Details